Obesity is a global epidemic and a major cause of morbidity and mortality because it increases the risk for comorbidities, ...

Cancer Immunotherapy, LYMPHIR, launched in the U.S. in December 2025 Completed $36 million in strategic financings, of which $18 million was via private placement and ...

Opioid receptors are a subset of G protein–coupled receptors (GPCRs). These membrane proteins transmit signals into the cell ...

University of Hawaiʻi Cancer Center researchers found in laboratory and animal models that when breast cancers stop ...

Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), ...

“These findings by our University of Hawai‘i Cancer Center research team show that drug resistance is not necessarily the end ...

For patients living with HER2-positive metastatic breast cancer, the recent FDA approval of trastuzumab deruxtecan (brand ...

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

Abstract: The safeguard of drug security is an important prerequisite to guarantee public health and life safety. The pre-warning mechanism is an important means to monitor drug risks quickly and ...

Researchers at Texas Biologics have made an important discovery that could improve treatment of human cytomegalovirus (HCMV), a common but overlooked virus that poses serious risks to vulnerable ...

Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an ...

Many people stop taking cholesterol-lowering statins because they experience muscle aches, weakness, and fatigue.